Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CH4 Global is an environmental biotechnology company dedicated to drastically reducing methane emissions from livestock to impact climate change. The company leverages the unique properties of Asparagopsis seaweed to develop feed supplements, such as its flagship product Methane Tamer, which can reduce enteric methane emissions by up to 90%. By scaling the aquaculture and processing of this specific red seaweed, CH4 Global provides a turnkey solution for the global beef and dairy industries. Their approach combines advanced marine science with industrial-scale manufacturing to create a sustainable and economically viable path for carbon footprint reduction in agriculture.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CH4 Global.